Premium
Indolent CD8 ‐positive lymphoid proliferation of acral sites: three further cases of a rare entity and an update on a unique patient
Author(s) -
Kluk Justine,
Kai Anneke,
Koch Dimitra,
Taibjee Saleem M.,
O'Connor Simon,
Persic Mojca,
Morris Stephen,
Whittaker Sean,
Cerroni Lorenzo,
Kempf Werner,
Petrella Tony,
Robson Alistair
Publication year - 2016
Publication title -
journal of cutaneous pathology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.597
H-Index - 75
eISSN - 1600-0560
pISSN - 0303-6987
DOI - 10.1111/cup.12633
Subject(s) - medicine , lymphoma , pathology , cd8 , disease , lymphatic system , immunology , immune system
Background Primary cutaneous indolent CD8 ‐positive lymphoid proliferation is an emerging entity characterized by slowly enlarging papules and nodules that are pathologically comprised of clonal nonepidermotropic medium‐sized atypical CD8 (+) T‐cells. Although the majority of lesions are solitary and located on the ears, bilateral symmetrical presentations have been described and lesions may arise at other peripheral or ‘acral’ sites. Patients follow a benign clinical course and systemic involvement has not yet been observed. Despite this, some medical practitioners classify such lesions as peripheral T‐cell lymphoma, NOS , a category implying aggressive disease. Objectives We present three cases seen in our institutions and provide an update on a previously reported unique patient who continues to develop recurrent and multifocal skin lesions. Results Systemic disease progression has not been observed, even in the presence of recurrent and multifocal cutaneous disease. Conclusions Indolent CD8 ‐positive lymphoid proliferation of acral sites is a distinctive and readily identifiable entity and should be included in the next consensus revision of cutaneous lymphoma classification. Although cases described thus far have followed an indolent clinical course, dermatologists should remain guarded about the prognosis and full staging and longitudinal observation are recommended until this condition is better understood.